Gene · 4821
Papers1,860
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,860
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary mesenchymal chondrosarcoma of the adult lumbar spine: a case report and review of the literature. | Transl Cancer Res | 2022 | 36237229 | PubTator, text mining | PubMed |
| Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. | Int J Mol Sci | 2022 | 36232796 | PubTator, text mining | PubMed |
| Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers. | Cells | 2022 | 36231030 | PubTator, text mining | PubMed |
| Fast generation of forebrain oligodendrocyte spheroids from human embryonic stem cells by transcription factors. | iScience | 2022 | 36217550 | PubTator, text mining | PubMed |
| Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects. | BMC Med Genomics | 2022 | 36209093 | PubTator, text mining | PubMed |
| Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. | Sci Adv | 2022 | 36197983 | PubTator, text mining | PubMed |
| AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells. | PLoS One | 2022 | 36194562 | PubTator, text mining | PubMed |
| A heterozygous LAMA5 variant may contribute to slowly progressive, vinculin-enhanced familial FSGS and pulmonary defects. | JCI Insight | 2022 | 36173685 | PubTator, text mining | PubMed |
| TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation. | Cell Death Dis | 2022 | 36171207 | PubTator, text mining | PubMed |
| Ewing sarcoma of the ileum with wide multiorgan metastases: A case report and review of literature. | World J Gastrointest Oncol | 2022 | 36160753 | PubTator, text mining | PubMed |
| Stem cell therapy for insulin-dependent diabetes: Are we still on the road? | World J Stem Cells | 2022 | 36157527 | PubTator, text mining | PubMed |
| Generation of a TPH2-EGFP reporter cell line for purification and monitoring of human serotonin neurons in vitro and in vivo. | Stem Cell Reports | 2022 | 36150384 | PubTator, text mining | PubMed |
| A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2022 | 36142575 | PubTator, text mining | PubMed |
| Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical Workup. | Cancers (Basel) | 2022 | 36139607 | PubTator, text mining | PubMed |
| Reprogramming-Evolving Path to Functional Surrogate β-Cells. | Cells | 2022 | 36139388 | PubTator, text mining | PubMed |
| Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma. | Curr Oncol | 2022 | 36135073 | PubTator, text mining | PubMed |
| Multidimensional analysis and therapeutic development using patient iPSC-derived disease models of Wolfram syndrome. | JCI Insight | 2022 | 36134655 | PubTator, text mining | PubMed |
| EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma. | Nucleic Acids Res | 2022 | 36124657 | PubTator, text mining | PubMed |
| Educational Case: Ewing sarcoma family of tumors: Clinical presentation, pathologic findings, and differential diagnosis. | Acad Pathol | 2022 | 36120708 | PubTator, text mining | PubMed |
| An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. | NPJ Precis Oncol | 2022 | 36115869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/papers?page=21